The frail, elderly population is often characterized by poor immunogenicity post COVID-19 mRNA vaccination. "Inflame-ageing" and "immune-senescence" are pathogenetic mechanisms that might explain this phenomenon. Complex interplay with cytokines and microbiota is also implicated in this inflammatory cascade. The abovementioned population, although very important from immunologic perspective, has barely been included in the mRNA vaccination clinical trials.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962607 | PMC |
| http://dx.doi.org/10.3390/medicina59020202 | DOI Listing |
Publication Analysis
Top Keywords
covid-19 mrna
8
mrna vaccination
8
mrna vaccine
4
vaccine effectiveness
4
effectiveness elderly
4
elderly frail
4
frail people
4
people frail
4
frail elderly
4
elderly population
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!